Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBlackRock Smaller Companies Trust PLC Regulatory News (BRSC)

Share Price Information for BlackRock Smaller Companies Trust PLC (BRSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,400.00
Bid: 1,400.00
Ask: 1,402.00
Change: 12.00 (0.86%)
Spread: 2.00 (0.143%)
Open: 1,400.00
High: 1,404.00
Low: 1,398.00
Prev. Close: 1,388.00
BRSC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

17 Apr 2018 11:31

BlackRock Smaller Companies Trust Plc - Portfolio Update

BlackRock Smaller Companies Trust Plc - Portfolio Update

PR Newswire

London, April 17

BLACKROCK SMALLER COMPANIES TRUST PLC (LEI: 549300MS535KC2WH4082) 

All information is at 31 March 2018 and unaudited.Performance at month end is calculated on a capital only basis

One month %Three months %One year %Three years %Five years %
Net asset value*-1.5-2.516.157.0102.1
Share price*1.53.128.765.0114.9
Numis ex Inv Companies + AIM Index-1.5-6.54.424.238.7

*performance calculations based on a capital only NAV with debt at par, without income reinvested. Share price performance calculations exclude income reinvestment.Sources: BlackRock and Datastream

At month end
Net asset value Capital only(debt at par value):1,464.64p
Net asset value Capital only(debt at fair value):1,456.32p
Net asset value incl. Income(debt at par value)**:1,487.16p
Net asset value incl. Income(debt at fair value)**:1,478.83p
Share price1,345.00p
Discount to Cum Income NAV (debt at par value):9.6%
Discount to Cum Income NAV (debt at fair value):9.0%
Net yield^^^:1.7%
Gross assets^:£786.7m
Gearing range as a % of net assets:0-15%
Net gearing including income (debt at par):10.3%
2017 Ongoing charges ratio^^0.7%
2017 Ongoing charges ratio (including performance fees):1.0%
Ordinary shares in issue#:47,879,792

**includes net revenue of 22.52p

^includes current year revenue

^^As reported in the Annual Financial Report for the year ended 28 February 2017, the ongoing charges ratio is calculated as a percentage of net assets and using operating expenses, excluding performance fees, finance costs and taxation.

^^^Yield calculations are based on dividends announced in the last 12 months as at the date of release of this announcement, and comprise of the final dividend of 13.00 pence per share, (announced on 02 May 2017, ex-dividend on 18 May 2017) and the interim dividend of 10.00 pence per share (announced on 30 October 2017 and gone ex-dividend on 9 November 2017)

#excludes 2,113,731 shares held in treasury.

Sector Weightings% of portfolio
Industrials33.9
Financials17.9
Consumer Services12.8
Technology8.2
Consumer Goods8.1
Basic Materials7.9
Health Care7.8
Oil & Gas3.0
Utilities0.4
-----
Total100.0
=====

Ten Largest Equity Investments
Company% of portfolio
Dechra Pharmaceuticals2.1
Robert Walters2.0
Central Asia Metals1.8
Ibstock1.7
Hill & Smith1.6
Avon Rubber1.6
CVS Group1.6
Big Yellow1.6
Accesso Technology1.4
4imprint Group 1.4

Commenting on the markets, Mike Prentis, representing the Investment Manager noted: 

During March the Company’s NAV per share fell by 1.5% to 1,464.64p on a capital only basis, in line with our benchmark index; the FTSE 100 Index fell 2.4% on a capital only basis.

March was a tough month for UK consumer exposed companies. Long term holding Headlam reported full year earnings per share up by 6.3%, strong cash generation and net cash of £35 million. However, Headlam also reported that January and February trading had been weak, although these are the quietest months of the year for the company. The shares fell 19% during the month and were our largest detractor from a relative contribution point of view, costing us 0.21% of net assets. We reduced our holding to 0.5% of net assets, on the basis that a quick recovery is unlikely.

On the positive side we did not own shares in Conviviality, the drinks supplier, which collapsed into administration during the month. Conviviality was in our benchmark, so not owning the shares helped our relative performance.

Amongst stocks we own we saw further good performances by Avon Rubber, Dechra Pharmaceuticals, Hill & Smith, YouGov and Zotefoams, all of which contributed usefully to relative performance.

We sold a few smaller, lower conviction holdings during the month. 

17 April 2018ENDS 

Latest information is available by typing www.blackrock.co.uk/brsc on the internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV terminal). Neither the contents of the Manager’s website nor the contents of any website accessible from hyperlinks on the Manager’s website (or any other website) is incorporated into, or forms part of, this announcement.

Date   Source Headline
26th Apr 202411:46 amPRNNet Asset Value(s)
25th Apr 20245:19 pmPRNHolding(s) in Company
25th Apr 202412:15 pmPRNNet Asset Value(s)
24th Apr 202412:15 pmPRNNet Asset Value(s)
23rd Apr 202412:13 pmPRNNet Asset Value(s)
22nd Apr 202411:54 amPRNNet Asset Value(s)
19th Apr 202412:07 pmPRNNet Asset Value(s)
18th Apr 202412:17 pmPRNNet Asset Value(s)
18th Apr 20247:00 amPRNTotal Voting Rights
17th Apr 202412:14 pmPRNNet Asset Value(s)
17th Apr 20247:00 amPRNTotal Voting Rights
16th Apr 20245:40 pmPRNTransaction in Own Shares
16th Apr 202412:02 pmPRNNet Asset Value(s)
16th Apr 20247:00 amPRNTotal Voting Rights
15th Apr 20245:53 pmPRNTransaction in Own Shares
15th Apr 202411:38 amPRNNet Asset Value(s)
12th Apr 20246:52 pmPRNTransaction in Own Shares
12th Apr 202412:15 pmPRNNet Asset Value(s)
11th Apr 202412:43 pmPRNHolding(s) in Company
11th Apr 202412:12 pmPRNNet Asset Value(s)
11th Apr 20247:00 amPRNTotal Voting Rights
10th Apr 202412:07 pmPRNNet Asset Value(s)
10th Apr 20247:00 amPRNTotal Voting Rights
9th Apr 20245:47 pmPRNTransaction in Own Shares
9th Apr 202411:45 amPRNNet Asset Value(s)
9th Apr 20247:00 amPRNTotal Voting Rights
8th Apr 20245:59 pmPRNTransaction in Own Shares
8th Apr 202412:00 pmPRNNet Asset Value(s)
8th Apr 20247:00 amPRNTotal Voting Rights
5th Apr 20245:45 pmPRNTransaction in Own Shares
5th Apr 202412:15 pmPRNNet Asset Value(s)
5th Apr 20247:00 amPRNTotal Voting Rights
4th Apr 20245:46 pmPRNTransaction in Own Shares
4th Apr 202412:03 pmPRNNet Asset Value(s)
4th Apr 20247:00 amPRNTotal Voting Rights
3rd Apr 20245:34 pmPRNTransaction in Own Shares
3rd Apr 202412:08 pmPRNNet Asset Value(s)
3rd Apr 20247:00 amPRNTotal Voting Rights
3rd Apr 20247:00 amPRNTransaction in Own Shares
2nd Apr 20241:00 pmPRNMandatory Closed Period Compliance with MAR
2nd Apr 202412:08 pmPRNNet Asset Value(s)
2nd Apr 20247:00 amPRNTotal Voting Rights
28th Mar 20246:22 pmPRNTransaction in Own Shares
28th Mar 202411:45 amPRNNet Asset Value(s)
28th Mar 20247:00 amPRNTotal Voting Rights
27th Mar 20245:49 pmPRNTransaction in Own Shares
27th Mar 20244:03 pmPRNPortfolio Update
27th Mar 202412:13 pmPRNNet Asset Value(s)
27th Mar 20247:00 amPRNTotal Voting Rights
26th Mar 20246:39 pmPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.